Tenderwize
Wróć do wyszukiwania

Open-house rebate agreements for Nitrendipin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 218 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nitrendipin, ATC C08CA08

52/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

52 / 100

Złożoność

58 / 100

Czynniki ryzyka

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive supply/rebate agreements for pharmaceutical products containing Nitrendipin (ATC C08CA08).
  • Open-house model with uniform terms for all participating pharmaceutical companies.
Pokaż pełne podsumowanie

This is an open-house pharmaceutical supply notice for non-exclusive rebate agreements on the active substance Nitrendipin (ATC C08CA08) for AOK Rheinland-Pfalz/Saarland. The model is not a standard competitive public procurement, but the notice still sets formal submission and eligibility conditions. Contracts can start from 01.06.2025 and run for up to 24 months, with monthly entry possible during the term. No contract value is stated. Procurement documents are available via a URL, but no extracted contract document text was provided, so they were not analyzed.

Ryzyka

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Only authorized and marketable medicines in Germany may be supplied under the contract.

Administrative

  • If the product is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided.
  • The AMIce extract must show name, MA holder or other marketing authorization basis, dosage form, active substance, and marketability.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreements for Nitrendipin

Single lot covering non-exclusive open-house rebate agreements for medicines containing the active substance Nitrendipin (ATC C08CA08). The scope excludes children’s medicines on the BfArM list under §35(5a) SGB V. The buyer states that terms are uniform for all participants, with no individual negotiations. Information in this lot comes from the structured data and XML notice.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
236770-2025

Dokumenty (1)

Podobne przetargi